44795-Lin, Tsai-Yu

Tsai-Yu Lin, PhD

Assistant Professor of Clinical Medical & Molecular Genetics

Associate Director of Gene Therapy Testing Laboratory

(317) 278-1627
980 W Walnut Street
Room R3 C647
Indianapolis, IN 46202
Pubmed Logo


Dr. Tsai-Yu Lin received his Ph.D. degree from the University of Washington. He subsequently worked as a postdoctoral scientist at the National Institute of Allergy and Infectious Diseases (NIAID), the University of Massachusetts Medical School, and Indiana University Purdue University Indianapolis (IUPUI). Prior to his IU School of Medicine (IUSM) employment, Dr. Lin had many years of experience as a senior researcher in the biotech industry, applying lentiviral vectors to gene delivery in the fields of gene therapy and immuno-oncology (e.g., CAR-T). Through his training and work experience, Dr. Lin has equipped himself with expertise in many aspects of medical virology (e.g., HIV, West Nile virus, dengue virus, alphaviruses, and hepatitis B virus), lentiviral vector technology, immuno-oncology, and gene therapy. As Associate Director of the Gene Therapy Testing Laboratory at IUSM, Dr. Lin focuses on molecular testing and analysis of gene and cell therapy product safety.

Key Publications

Cornetta K, Lin TY, Pellin D, Kohn DB. Meeting FDA guidance recommendations for replication competent virus and insertional oncogenesis testing. Mol Ther Methods Clin Dev. 2023; 28:28-39.

Cornetta K, Yao J, House K, Duffy L, Adusumilli PS, Beyer R, Booth C, Brenner M, Curran K, Grilley B, Heslop H, Hinrichs CS, Kaplan RN, Kiem HP, Kochenderfer J, Kohn DB, Mailankody S, Norberg SM, O'Cearbhaill RE, Pappas J, Park J, Ramos C, Ribas A, Rivière I, Rosenberg SA, Sauter C, Shah NN, Slovin SF, Thrasher A, Williams DA, Lin TY. Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR In 1595 post-treatment peripheral blood samples obtained from 60 clinical trials. Mol Ther. 2023; 31(3)801-9.

Lin TY, Chin CR, Everitt AR, Clare S, Perreira JM, Savidis G, Aker AM, John SP, Sarlah D, Carreira EM, Elledge SJ, Kellam P, Brass AL. Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell reports. 2013; 5(4):895-908.

Lin TY, Dowd KA, Manhart CJ, Nelson S, Whitehead SS, Pierson TC. A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus. Journal of virology. 2012; 86(7):3501-12.

Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M Jr, Shi PY, Diamond MS. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature. 2010; 468(7322):452-6.

Lin TY, Emerman M. Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1. Virology. 2008; 379(2):335-41.

Lin TY, Emerman M. Cyclophilin A interacts with diverse lentiviral capsids. Retrovirology. 2006; 3:70.

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.